Biotechnology Drug Delivery
Lyra Therapeutics is a clinical-stage company developing medicines precisely designed to target ear, nose and throat (ENT) diseases.
Our goal is to transform the ENT treatment paradigm by providing effective front-line solutions for physicians and new treatment options for their patients.
Building on expertise in materials science, drug development and formulation, the Lyra team has developed a proprietary platform that is designed to enable long-acting, local delivery of medications over an extended period of time, directly targeting tissue deep in the nasal passages. Based on clinical results, this new therapeutic approach has the potential to provide significantly improved patient outcomes beyond the limited treatment and surgical options currently available for ENT diseases.
Headquartered in the Boston area, Lyra Therapeutics was founded by academic luminaries in the fields of chemistry, materials science and biotechnology, and is backed by leading life science investors.
Get your company on the map with a MassMEDIC membership
Welcome to MassMEDIC’s new directory of the New England medtech ecosystem. This is one of the most comprehensive and exhaustive directories of the companies involved in the medtech industry, which we have compiled for more than two decades.
For the first time, you can search for companies based on location, zip code or business category. In addition, you can locate where these companies are with our geo-located map. While we happy to list all the companies involved in this critical industry, only MassMEDIC members will have their company's contact information visible. If you wish to upgrade your companies listing by becoming a member, contact us we will be happy to get you started.
P.S. Did you know MassMEDIC members can get special discounts to several key suppliers? Check out our New England Edge program for more details.